TrialAmerican journal of obstetrics and gynecology2016

Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.

Tracy A Manuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.